In a study on TNBC, it was observed that dual inhibition of CDK4/6 and CDK7 suppressed tumor growth by reducing SREBP1 without having a significant effect on SREBP2; nevertheless, downstream cholesterol biosynthesis was lowered [94]. Here, SREBF1 is linked to neoplasm.